Lv1
70 积分 2024-10-09 加入
Identification of CD28 and PTEN as novel prognostic markers for cervical cancer
9天前
已完结
PIK3CA Mutations and Their Impact on Survival Outcomes of Patients with Cervical Cancer: A Systematic Review
9天前
已完结
Discovery of highly potent and selective CRBN-recruiting EGFRL858R/T790M degraders in vivo
10天前
已完结
TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers
14天前
已完结
Icotinib in a lung adenocarcinoma patient with acquired EGFR 19del/C797S mutation-mediated resistance to osimertinib: a case report
15天前
已完结
Treatment of HER2-positive cutaneous apocrine carcinoma of the axilla
15天前
已完结
VP2-2024: Fuzuloparib with or without apatinib in HER2- metastatic breast cancer (mBC) patients (pts) with germline BRCA1/2 mutations (gBRCA1/2m): A randomized phase III trial
16天前
已完结
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
17天前
已完结
Discovery of JNJ-63576253: A Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC)
17天前
已完结
Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma
21天前
已完结
皖公网安备34019202002308
